Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leavesnews2025-02-28T12:00:38+00:00February 28th, 2025|Endpoints News|
Merck KGaA tees up changes to leadership team; Ex-CVS Health CEO joins Thermo Fisher’s boardnews2025-02-21T12:00:00+00:00February 21st, 2025|Endpoints News|
David Schenkein resigns from Agios’ board; Moderna hires Roivant exec as chief marketing officernews2025-02-14T12:00:34+00:00February 14th, 2025|Endpoints News|
Longtime Sandoz exec announces retirement; Lilly appoints head of Indianews2025-02-07T12:00:12+00:00February 7th, 2025|Endpoints News|
Roche separates CFO, informatics posts; Lilly execs land at Kailera, Neurocrinenews2025-01-31T12:00:14+00:00January 31st, 2025|Endpoints News|
Moderna information chief to retire next month; Pharming looks to Flagship for first new CEO since 2008news2025-01-24T12:00:32+00:00January 24th, 2025|Endpoints News|
Kathy High leads GV, ARCH-backed eye disease biotech; Arvinas commercial exec steps downnews2025-01-17T12:00:33+00:00January 17th, 2025|Endpoints News|
John Maraganore turns to ex-Alnylam colleague to lead his latest RNAi bet; Amylyx names commercial chiefnews2025-01-10T12:00:26+00:00January 10th, 2025|Endpoints News|
Daiichi Sankyo finds successor to late R&D exec; Versant, Novartis’ kidney biotech poaches Sana CBOnews2024-12-20T12:00:02+00:00December 20th, 2024|Endpoints News|
Xaira hires former Roche exec as CMO; ‘Tis the season for retirements at Alnylam, Regeneronnews2024-12-13T12:00:58+00:00December 13th, 2024|Endpoints News|
